Stop using nowDrug recall · FDA · Published May 1, 2018
AuroMedics Ampicillin/Sulb: Red rubber particles risk in injections
AuroMedics Pharma recalls 3g vials of Ampicillin/Sulbactam injections due to reported red rubber particles. Stop using if you have these specific lots.
Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.
“AuroMedics Ampicillin/Sulb: Red rubber particles risk in injections.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40580-auromedics-ampicillin-sulb-red-rubber-particles-risk-in-injections. Based on FDA recall #D-0866-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0866-2018%22&limit=1).
The FDA announced on May 1, 2018, that AuroMedics Pharma LLC voluntarily recalled Ampicillin and Sulbactam for Injection due to the presence of visible particulate matter. The recall affects 54,720 vials distributed nationwide.
How to tell if you have it
Brand: AuroMedics
Product: Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial
NDC: 55150-117-20
Lot codes: AS0317041-A, AS0317035-A
Expiration: August 2019
The hazard
The recall was issued after a confirmed customer report of visible particulate matter believed to be red rubber particles from the manufacturing process. The FDA classified this as a Class I recall.
Context
GovInfoNow's records show AuroMedics Pharma LLC has 22 other recalls on record since December 4, 2017. Recent similar recalls include an AuroMedics Fondaparinux Injection recall on September 30, 2022, for subpotent drug risk and an AuroMedics Tranexamic Acid Injection recall on September 26, 2022, for metal particulate hazard. Other recent recalls of similar products include Sun Pharmaceutical DOXOrubin Liposome Injection (May 12, 2026) and American Regent Atropine Sulfate Injection (July 24, 2026).
How to tell if you have this one
Check your vial label for the lot numbers AS0317035-A or AS0317041-A. The product was manufactured for intramuscular or intravenous use and expires August 2019.
Brand
AuroMedics
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
Discard the vial if you have the recalled lot numbers AS0317035-A or AS0317041-A.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 6.5 years after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class I
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0866-2018 (May 1, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0866-2018 to see it in context.
Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.